Efficacy and Safety of Intravitreal Aflibercept for Choroidal Neovascularization Secondary to Pathological Myopia: 48-week Results of MYRROR Study
Year: 2014
Type: article
Institutions: National University of Singapore, Duke-NUS Medical School, Kyushu University, Kyushu University Hospital, Tokyo Medical and Dental University, Osaka University Hospital, Centre Hospitalier Universitaire de Bordeaux, Hôpital Pellegrin, Bayer (Germany), Bayer (Japan), Bayer (China), Regeneron (United States)
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W770491961
